Dr. Kim Jeongeun of Gangnam Main Branch Delivers Academic Seminar on Adipose-Derived Stem Cells
Dr. Kim Jeongeun of 365mc delivered an academic seminar on adipose-derived stem cells, covering cell viability, hair treatment applications, and regenerative IV programs.
Hello, this is LipoManiac 365.
On February 24, 2026, Dr. Kim Jeongeun, MD, Medical Director of 365mc’s first Stem Cell Center, delivered an online academic lecture for the surgical directors on the topic of adipose-derived stem cells.
Dr. Kim Jeongeun was elected as the inaugural President of the Korean Society of Adipose-Derived Stem Cells and continues to lead academic advancement in this field.
During this session, she shared in-depth insights centered on her accumulated clinical experience and research findings.
The lecture covered key factors affecting cell viability and combination treatment strategies to enhance it, as well as the role of growth factors secreted by stem cells.
Dr. Kim also emphasized that adipose-derived stem cells allow for cell yield up to 2.5 million times higher than blood-derived cells and maintain stable harvesting rates even with aging—highlighting their strong clinical value.
Why Is Adipose Stem Cell Scalp Injection Drawing Global Attention?
The seminar reviewed domestic and international clinical studies applying adipose-derived stem cells to hair loss treatment, introducing research findings related to improvements in hair density and thickness.
In particular, 365mc’s Stem Cell Hair Shot was highlighted for its clinical advantages, including localized cryo-anesthesia to reduce discomfort and a minimally invasive approach with minimal bleeding—practical strengths demonstrated in real clinical settings.
What Do Clinical Cases Show About the Stem Cell Bio Shot (IV)?
Clinical experience with the Stem Cell Bio Shot (IV)—an intravenous adipose stem cell program—was also presented.
In actual IV administration cases, improvements were reported in vitality, vision, musculoskeletal symptoms, menopausal symptoms, and blood glucose levels, demonstrating the potential for overall systemic condition enhancement.
As Korea’s first hospital dedicated exclusively to fat research for 23 years, and as a Ministry of Health and Welfare–designated Advanced Regenerative Medicine Institution, 365mc will continue advancing clinical and academic leadership in adipose stem cell–based regenerative medicine.
Thank you.
